Luyan Pharma Co.,Ltd. (002788.SZ)
CNY 8.08
(0.62%)
CNY 8.08
(0.62%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 1.5 Billion CNY | -0.4% |
| 2022 | 1.51 Billion CNY | 10.5% |
| 2021 | 1.37 Billion CNY | 11.1% |
| 2020 | 1.23 Billion CNY | 5.54% |
| 2019 | 1.16 Billion CNY | 29.95% |
| 2018 | 899.9 Million CNY | 38.49% |
| 2017 | 649.8 Million CNY | 22.56% |
| 2016 | 530.2 Million CNY | 0.39% |
| 2015 | 528.17 Million CNY | -1.54% |
| 2014 | 536.44 Million CNY | 13.86% |
| 2013 | 471.12 Million CNY | 30.82% |
| 2012 | 360.13 Million CNY | 53.86% |
| 2011 | 234.06 Million CNY | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 378.15 Million CNY | -10.22% |
| 2024 Q2 | 348.94 Million CNY | -7.73% |
| 2024 Q3 | 360.95 Million CNY | 3.44% |
| 2023 Q2 | 379.98 Million CNY | 4.86% |
| 2023 Q4 | 421.21 Million CNY | 21.91% |
| 2023 FY | 1.5 Billion CNY | -0.4% |
| 2023 Q3 | 345.49 Million CNY | -9.07% |
| 2023 Q1 | 362.37 Million CNY | -15.81% |
| 2022 Q3 | 364.09 Million CNY | -4.45% |
| 2022 FY | 1.51 Billion CNY | 10.5% |
| 2022 Q4 | 430.4 Million CNY | 18.21% |
| 2022 Q2 | 381.03 Million CNY | 12.19% |
| 2022 Q1 | 339.63 Million CNY | -8.53% |
| 2021 FY | 1.37 Billion CNY | 11.1% |
| 2021 Q3 | 342.34 Million CNY | 0.33% |
| 2021 Q4 | 371.29 Million CNY | 8.46% |
| 2021 Q2 | 341.2 Million CNY | 7.86% |
| 2021 Q1 | 316.33 Million CNY | -4.17% |
| 2020 Q3 | 323.37 Million CNY | 1.17% |
| 2020 Q2 | 319.62 Million CNY | 22.42% |
| 2020 FY | 1.23 Billion CNY | 5.54% |
| 2020 Q1 | 261.09 Million CNY | -17.55% |
| 2020 Q4 | 330.09 Million CNY | 2.08% |
| 2019 Q3 | 303.72 Million CNY | 0.7% |
| 2019 FY | 1.16 Billion CNY | 29.95% |
| 2019 Q2 | 301.59 Million CNY | 21.9% |
| 2019 Q1 | 247.41 Million CNY | -0.98% |
| 2019 Q4 | 316.65 Million CNY | 4.26% |
| 2018 Q2 | 221.28 Million CNY | 13.44% |
| 2018 Q4 | 249.87 Million CNY | 6.94% |
| 2018 FY | 899.9 Million CNY | 38.49% |
| 2018 Q3 | 233.66 Million CNY | 5.59% |
| 2018 Q1 | 195.06 Million CNY | -1.47% |
| 2017 Q1 | 122.01 Million CNY | -12.97% |
| 2017 FY | 649.8 Million CNY | 22.56% |
| 2017 Q3 | 171.61 Million CNY | 8.48% |
| 2017 Q4 | 197.97 Million CNY | 15.36% |
| 2017 Q2 | 158.19 Million CNY | 29.65% |
| 2016 Q1 | 117.19 Million CNY | -21.81% |
| 2016 Q2 | 145.6 Million CNY | 24.25% |
| 2016 Q4 | 140.2 Million CNY | 10.23% |
| 2016 FY | 530.2 Million CNY | 0.39% |
| 2016 Q3 | 127.19 Million CNY | -12.65% |
| 2015 Q4 | 149.88 Million CNY | 17.65% |
| 2015 Q1 | 119.83 Million CNY | 0.0% |
| 2015 Q3 | 127.4 Million CNY | -2.78% |
| 2015 FY | 528.17 Million CNY | -1.54% |
| 2015 Q2 | 131.04 Million CNY | 9.35% |
| 2014 FY | 536.44 Million CNY | 13.86% |
| 2013 FY | 471.12 Million CNY | 30.82% |
| 2012 FY | 360.13 Million CNY | 53.86% |
| 2011 FY | 234.06 Million CNY | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Cachet Pharmaceutical Co., Ltd. | 1.97 Billion CNY | 23.827% |
| Yixintang Pharmaceutical Group Co., Ltd. | 5.55 Billion CNY | 72.861% |
| ZJAMP Group Co., Ltd. | 2.51 Billion CNY | 40.177% |
| Ji Yao Holding Group Co., Ltd. | 81.67 Million CNY | -1744.385% |